Roland Mahr Joins InClinica as Vice President and General Manager of Asia-Pacific
PHILADELPHIA (SEPTEMBER 21, 2017) – InClinica, a global clinical CRO, announced that Roland Mahr has been appointed as Vice President and General Manager of Asia-Pacific. In his new role, he will oversee all aspects of the company’s Asia-Pacific operations.
Mahr has more than 20 years of experience in financial management, operations, strategic planning and business development with deep knowledge in the biopharmaceutical space. Before joining InClinica, he served as Vice President of Finance at LF Asia where he was responsible for finance, customer service and legal functions of multiple business units. Prior to that, he spent more than a decade working in multiple financial leadership roles within Pfizer.
“We are thrilled to welcome Roland to the InClinica team, and look forward to expanding in the Asia-Pacific region,” said James Nolan, CEO at InClinica. “His deep experience in biopharma with an eye toward business growth will be exceptionally valuable in strengthening our western operations.”
Mahr holds an M.S. in Industrial Administration from Carnegie Mellon University, and a B.B.A. in Accounting from the University of Texas.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.